Biophore applies to DCGI for emergency-use approval for COVID-19 treatment drug

FDC launches 2 variants of Favipiravir in India at Rs 55 per tablet

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

All you need to know about the drugs used in Covid-19 treatment

Remdesiver, Favipiravir ‘no game changers’ in COVID fight: Medical experts

Favipiravir: All you need to know about the potential drug for Covid-19 treatment

Latest Additions

NIA arrests key accused in 2023 attack on Indian High Commission in London

Three persons run over by train in Bengaluru

Indian nationals aboard ‘MSC Aries’ in good health, return delayed due to technicalities: MEA

Husband has no control over wife’s ‘stridhan’: SC

IT sleuths threatening raided leaders to claim money belongs to me, Cong: DK Shivakumar

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.